M1 Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$748K Buy
623
+4
+0.6% +$4.09K 0.28% 58
2026
Q1
$569K Buy
619
+71
+13% +$72K 0.26% 59
2025
Q4
$589K Buy
548
+15
+3% +$14.3K 0.25% 60
2025
Q3
$407K Buy
533
+52
+11% +$38.7K 0.18% 71
2025
Q2
$375K Buy
481
+100
+26% +$77.7K 0.19% 70
2025
Q1
$315K Buy
+381
New +$317K 0.2% 68

Other funds holding LLY

M1 Capital Management's LLY Position: Q2 2026 in Review

M1 Capital Management increased its Eli Lilly (LLY) stake by 0.65% in Q2 2026, buying an estimated $4.09K and bringing the position to 623 shares worth $748K. The position accounts for 0.28% of the portfolio, ranked #58.

M1 Capital Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • M1 Capital Management held 623 shares of Eli Lilly worth $748K as of Q2 2026.
  • M1 Capital Management bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.28% of M1 Capital Management's portfolio in Q2 2026, its #58 holding.
  • M1 Capital Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on M1 Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.